| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9307970 | Journal of Renal Nutrition | 2005 | 11 Pages |
Abstract
Megestrol acetate oral solution in half of its conventional dose is safe and improves the nutritional state, inflammation, and anorexia in maintenance dialysis patients. Larger-scale placebo-controlled randomized studies are needed to confirm the beneficial effects of 400 mg/day of megestrol acetate in dialysis patients.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Meenakshi MS, RD, Kamyar MD, PhD, MPH, Alexander MD, Cybele MD,